These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 21261594)
1. The evolution of histamine H₃ antagonists/inverse agonists. Lebois EP; Jones CK; Lindsley CW Curr Top Med Chem; 2011; 11(6):648-60. PubMed ID: 21261594 [TBL] [Abstract][Full Text] [Related]
2. Discovery of novel steroidal histamine H Ledneczki I; Tapolcsányi P; Gábor E; Éles J; Greiner I; Schmidt É; Némethy Z; Kedves RS; Balázs O; Román V; Lévay G; Mahó S Bioorg Med Chem Lett; 2017 Oct; 27(19):4525-4530. PubMed ID: 28888822 [TBL] [Abstract][Full Text] [Related]
3. Structure-based prediction of subtype selectivity of histamine H3 receptor selective antagonists in clinical trials. Kim SK; Fristrup P; Abrol R; Goddard WA J Chem Inf Model; 2011 Dec; 51(12):3262-74. PubMed ID: 22035233 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of constrained benzocinnolinone analogues of CEP-26401 (irdabisant) as potent, selective histamine H3 receptor inverse agonists. Josef KA; Aimone LD; Lyons J; Raddatz R; Hudkins RL Bioorg Med Chem Lett; 2012 Jun; 22(12):4198-202. PubMed ID: 22617490 [TBL] [Abstract][Full Text] [Related]
5. Progress in the development of histamine H Łażewska D; Kieć-Kononowicz K Expert Opin Ther Pat; 2018 Mar; 28(3):175-196. PubMed ID: 29334795 [TBL] [Abstract][Full Text] [Related]
6. Histamine H(3) receptor (H(3)R) antagonists and inverse agonists in the treatment of sleep disorders. Broderick M; Masri T Curr Pharm Des; 2011; 17(15):1426-9. PubMed ID: 21476958 [TBL] [Abstract][Full Text] [Related]
7. New developments around histamine H(3) receptor antagonists/inverse agonists: a patent review (2010 - present). Łażewska D; Kieć-Kononowicz K Expert Opin Ther Pat; 2014 Jan; 24(1):89-111. PubMed ID: 24131059 [TBL] [Abstract][Full Text] [Related]
8. Discovery of a new class of non-imidazole oxazoline-based histamine H(3) receptor (H(3)R) inverse agonists. Célanire S; Wijtmans M; Christophe B; Collart P; de Esch I; Dassesse D; Delaunoy C; Denonne F; Durieu V; Gelens E; Gillard M; Lallemand B; Lamberty Y; Lebon F; Nicolas JM; Quéré L; Snip E; Vanbellinghen A; Van Houtvin N; Verbois V; Timmerman H; Talaga P; Leurs R; Provins L ChemMedChem; 2009 Jul; 4(7):1063-8. PubMed ID: 19405064 [TBL] [Abstract][Full Text] [Related]
9. Discovery of novel lead in the group of N-substituted piperazine ether derivatives with potential histamine H3 receptor activity. Kuder KJ; Stachnik M; Schunack W; Szymańska E; Kieć-Kononowicz K Med Chem; 2014; 10(6):588-99. PubMed ID: 24047214 [TBL] [Abstract][Full Text] [Related]
10. Histamine H3 receptor function and ligands: recent developments. Singh M; Jadhav HR Mini Rev Med Chem; 2013 Jan; 13(1):47-57. PubMed ID: 22931528 [TBL] [Abstract][Full Text] [Related]
11. A robust and high-capacity [(35)S]GTPgammaS binding assay for determining antagonist and inverse agonist pharmacological parameters of histamine H(3) receptor ligands. Miller TR; Baranowski JL; Estvander BR; Witte DG; Carr TL; Manelli AM; Krueger KM; Cowart MD; Brioni JD; Esbenshade TA Assay Drug Dev Technol; 2008 Jun; 6(3):339-49. PubMed ID: 18593375 [TBL] [Abstract][Full Text] [Related]
13. The histamine H3 receptor as a therapeutic drug target for CNS disorders. Gemkow MJ; Davenport AJ; Harich S; Ellenbroek BA; Cesura A; Hallett D Drug Discov Today; 2009 May; 14(9-10):509-15. PubMed ID: 19429511 [TBL] [Abstract][Full Text] [Related]
14. The challenge of drug discovery of a GPCR target: analysis of preclinical pharmacology of histamine H3 antagonists/inverse agonists. Hancock AA Biochem Pharmacol; 2006 Apr; 71(8):1103-13. PubMed ID: 16513092 [TBL] [Abstract][Full Text] [Related]
15. Histamine H3-receptor inverse agonists as novel antipsychotics. Ito C Cent Nerv Syst Agents Med Chem; 2009 Jun; 9(2):132-6. PubMed ID: 20021346 [TBL] [Abstract][Full Text] [Related]
16. Several down, a few to go: histamine H3 receptor ligands making the final push towards the market? Kuhne S; Wijtmans M; Lim HD; Leurs R; de Esch IJ Expert Opin Investig Drugs; 2011 Dec; 20(12):1629-48. PubMed ID: 21992603 [TBL] [Abstract][Full Text] [Related]
17. 4-Hydroxypiperidines and Their Flexible 3-(Amino)propyloxy Analogues as Non-Imidazole Histamine H₃ Receptor Antagonist: Further Structure⁻Activity Relationship Exploration and In Vitro and In Vivo Pharmacological Evaluation. Olszewska B; Stasiak A; McNaught Flores D; Fogel WA; Leurs R; Walczyński K Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29671795 [TBL] [Abstract][Full Text] [Related]
18. Non-Imidazole Histamine H3 Ligands. Part VI. Synthesis and Preliminary Pharmacological Investigation of Thiazole-Type Histamine H3-Receptor Antagonists with Lacking a Nitrogen Nucleus in the Side Chain. Guryn R; Staszewski M; Kopczacki P; Walczyski K Med Chem; 2016; 13(1):65-76. PubMed ID: 27220560 [TBL] [Abstract][Full Text] [Related]
19. SAR exploration of the non-imidazole histamine H Wágner G; Mocking TAM; Ma X; Slynko I; Da Costa Pereira D; Breeuwer R; Rood NJN; van der Horst C; Vischer HF; de Graaf C; de Esch IJP; Wijtmans M; Leurs R Arch Pharm (Weinheim); 2023 Jan; 356(1):e2200451. PubMed ID: 36310109 [TBL] [Abstract][Full Text] [Related]